Come up with a name for your new list and we'll add to it:
Agenta Biotechnologies raised a round of funding on July 05, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Agenta's technologies capitalize on variations of the important biomolecules called proteoglycans, a class of molecules that can promote healing through a variety of known mechanisms. As therapeutics…